Example of Annals of Clinical Microbiology and Antimicrobials format
Recent searches

Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format Example of Annals of Clinical Microbiology and Antimicrobials format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Annals of Clinical Microbiology and Antimicrobials — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Infectious Diseases #55 of 288 up up by 43 ranks
Microbiology (medical) #28 of 116 up up by 18 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 221 Published Papers | 1386 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 12/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Oxford University Press

Quality:  
High
CiteRatio: 9.1
SJR: 2.124
SNIP: 1.646
open access Open Access

Frontiers Media

Quality:  
High
CiteRatio: 6.5
SJR: 1.812
SNIP: 1.485
open access Open Access
recommended Recommended

American Society for Microbiology

Quality:  
High
CiteRatio: 39.4
SJR: 9.177
SNIP: 10.528
open access Open Access

Springer

Quality:  
High
CiteRatio: 5.9
SJR: 0.983
SNIP: 1.414

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.705

7% from 2018

Impact factor for Annals of Clinical Microbiology and Antimicrobials from 2016 - 2019
Year Value
2019 2.705
2018 2.924
2017 3.155
2016 2.376
graph view Graph view
table view Table view

6.3

11% from 2019

CiteRatio for Annals of Clinical Microbiology and Antimicrobials from 2016 - 2020
Year Value
2020 6.3
2019 5.7
2018 5.0
2017 4.1
2016 4.4
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has decreased by 7% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 11% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

1.194

7% from 2019

SJR for Annals of Clinical Microbiology and Antimicrobials from 2016 - 2020
Year Value
2020 1.194
2019 1.114
2018 1.06
2017 1.104
2016 1.042
graph view Graph view
table view Table view

1.817

35% from 2019

SNIP for Annals of Clinical Microbiology and Antimicrobials from 2016 - 2020
Year Value
2020 1.817
2019 1.35
2018 1.457
2017 1.25
2016 1.628
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 7% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 35% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Annals of Clinical Microbiology and Antimicrobials

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Annals of Clinical Microbiology and Antimicrobials

Approved by publishing and review experts on SciSpace, this template is built as per for Annals of Clinical Microbiology and Antimicrobials formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 914 authors to write and format their manuscripts to this journal.

i
Last updated on
12 Jun 2020
i
ISSN
1606-8610
i
Open Access
Yes
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Numbered
[25]
i
Bibliography Example
Blonder, G.E., Tinkham, M., Klapwijk, T.M.: Transition from metallic to tunneling regimes in superconducting microconstrictions: Excess current, charge imbalance, and supercurrent conversion. Phys. Rev. B 25(7), 4515–4532 (1982)

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1186/1476-0711-6-4
Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India
Mohammed Akram1, Mohammed Shahid, Asad U. Khan1

Abstract:

Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Current knowledge on antimicrobial susceptibility pattern is essential for appropriate therapy. Extended-Spectrum beta-Lactamase (ESBL) producing bacteria may not be detected by routine disk diffusion suscep... Urinary tract infections (UTIs) remain the common infections diagnosed in outpatients as well as hospitalized patients. Current knowledge on antimicrobial susceptibility pattern is essential for appropriate therapy. Extended-Spectrum beta-Lactamase (ESBL) producing bacteria may not be detected by routine disk diffusion susceptibility test, leading to inappropriate use of antibiotics and treatment failure. The aim of this study was to determine the distribution and antibiotic susceptibility patterns of bacterial strains isolated from patients with community acquired urinary tract infections (UTIs) at Aligarh hospital in India as well as identification of ESBL producers in the population of different uropathogens. Urinary isolates from symptomatic UTI cases attending to the JN Medical College and hospital at Aligarh were identified by conventional methods. Antimicrobial susceptibility testing was performed by Kirby Bauer's disc diffusion method. Isolates resistant to third generation cephalosporin were tested for ESBL production by double disk synergy test method. Of the 920 tested sample 100 samples showed growth of pathogens among which the most prevalent were E. coli (61%) followed by Klebsiella spp (22%). The majority (66.66%) of the isolates were from female while the remaining were from male. Among the gram-negative enteric bacilli high prevalence of resistance was observed against ampicillin and co-trimoxazole. Most of the isolates were resistant to 4 or more number of antibiotics. Forty two percent of isolates were detected to produce ESBL among which 34.42 % were E. coli isolates. This study revealed that E. coli was the predominant bacterial pathogen of community acquired UTIs in Aligarh, India. It also demonstrated an increasing resistance to Co-trimoxazole and production of extended spectrum β-lactamase among UTI pathogens in the community. This study is useful for clinician in order to improve the empiric treatment. read more read less

Topics:

Ampicillin (56%)56% related to the paper, Drug resistance (52%)52% related to the paper, Antibiotic resistance (51%)51% related to the paper, Population (51%)51% related to the paper, Antibiotics (51%)51% related to the paper
View PDF
548 Citations
open accessOpen access Journal Article DOI: 10.1186/1476-0711-5-2
Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States
David A. Styers, Daniel J. Sheehan1, Patricia A. Hogan1, Daniel F. Sahm

Abstract:

The virulence, antimicrobial resistance, and prevalence of S. aureus underscores the need for up-to-date and extensive insights regarding antimicrobial susceptibility trends. One approach to meet this need is analysis of clinical laboratory – based surveillance data. Data from The Surveillance Network-USA (TSN), an electronic... The virulence, antimicrobial resistance, and prevalence of S. aureus underscores the need for up-to-date and extensive insights regarding antimicrobial susceptibility trends. One approach to meet this need is analysis of clinical laboratory – based surveillance data. Data from The Surveillance Network-USA (TSN), an electronic surveillance network that collects microbiology data from 300 clinical microbiology laboratories across the United States, were used as the source for analysis that included prevalence of S. aureus in clinical specimens, MRSA and multi-drug resistance phenotype rates and trends according to patient location, geographic distributions, and specimen source. S. aureus was the most prevalent species isolated from inpatient specimens (18.7% of all bacterial isolates) and the second most prevalent (14.7%) from outpatient specimens. In March 2005 MRSA rates were 59.2%, 55%, and 47.9% for strains from non-ICU inpatients, ICU, and outpatients, respectively. This trend was noted in all nine US Bureau of Census regions and multi-drug resistance phenotypes (resistance to ≥ 3 non-beta-lactams) was common among both inpatient MRSA (59.9%) and outpatient MRSA (40.8%). Greater than 90% of multi-drug resistant MRSA were susceptible to trimethoprim-sulfamethoxazole, linezolid, and vancomycin. Prevalence of MRSA among both inpatient and outpatient specimens continues to increase with multi-drug resistance as a common phenotype. Continued emergence of outpatient MRSA that exhibit multi-drug resistant phenotypes has important implications for developing and evolving outpatient treatment guidelines. read more read less

Topics:

Drug resistance (52%)52% related to the paper, Antibiotic resistance (52%)52% related to the paper
View PDF
400 Citations
open accessOpen access Journal Article DOI: 10.1186/1476-0711-5-26
Community-acquired MRSA and pig-farming.

Abstract:

Background Sporadic cases of CA-MRSA in persons without risk-factors for MRSA carriage are increasing.
View PDF
382 Citations
open accessOpen access Journal Article DOI: 10.1186/1476-0711-12-22
New antibiotics for bad bugs: where are we?

Abstract:

Bacterial resistance to antibiotics is growing up day by day in both community and hospital setting, with a significant impact on the mortality and morbidity rates and the financial burden that is associated. In the last two decades multi drug resistant microorganisms (both hospital- and community-acquired) challenged the sci... Bacterial resistance to antibiotics is growing up day by day in both community and hospital setting, with a significant impact on the mortality and morbidity rates and the financial burden that is associated. In the last two decades multi drug resistant microorganisms (both hospital- and community-acquired) challenged the scientific groups into developing new antimicrobial compounds that can provide safety in use according to the new regulation, good efficacy patterns, and low resistance profile. In this review we made an evaluation of present data regarding the new classes and the new molecules from already existing classes of antibiotics and the ongoing trends in antimicrobial development. Infectious Diseases Society of America (IDSA) supported a proGram, called “the ′10 × ´20′ initiative”, to develop ten new systemic antibacterial drugs within 2020. The microorganisms mainly involved in the resistance process, so called the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and enterobacteriaceae) were the main targets. In the era of antimicrobial resistance the new antimicrobial agents like fifth generation cephalosporins, carbapenems, monobactams, β-lactamases inhibitors, aminoglycosides, quinolones, oxazolidones, glycopeptides, and tetracyclines active against Gram-positive pathogens, like vancomycin-resistant S. aureus (VRSA) and MRSA, penicillin-resistant streptococci, and vancomycin resistant Enterococcus (VRE) but also against highly resistant Gram-negative organisms are more than welcome. Of these compounds some are already approved by official agencies, some are still in study, but the need of new antibiotics still does not cover the increasing prevalence of antibiotic-resistant bacterial infections. Therefore the management of antimicrobial resistance should also include fostering coordinated actions by all stakeholders, creating policy guidance, support for surveillance and technical assistance. read more read less

Topics:

Antibiotic resistance (60%)60% related to the paper, Antimicrobial (57%)57% related to the paper, Drug resistance (56%)56% related to the paper, Vancomycin-resistant Enterococcus (54%)54% related to the paper, Multiple drug resistance (53%)53% related to the paper
View PDF
372 Citations
open accessOpen access Journal Article DOI: 10.1186/S12941-017-0191-3
Systematic review and meta-analysis of mortality of patients infected with carbapenem-resistant Klebsiella pneumoniae
Liangfei Xu1, Xiaoxi Sun1, Xiaoling Ma1

Abstract:

Carbapenem resistant K. pneumoniae (CRKP) has aroused widespread attention owing to its very limited therapeutic options, and this strain has increased rapidly in recent years. Although it is accepted that drug resistance is associated with increased mortality in general, but some other studies found no such relationship. To ... Carbapenem resistant K. pneumoniae (CRKP) has aroused widespread attention owing to its very limited therapeutic options, and this strain has increased rapidly in recent years. Although it is accepted that drug resistance is associated with increased mortality in general, but some other studies found no such relationship. To estimate mortality of patients infected with CRKP in general and analyze factors for mortality of this infection, thus, we conducted this systematic review and meta-analysis. A systematic literature review of relevant studies published until December 2015 was conducted. We selected and assessed articles reporting mortality of patients infected with CRKP. Pooled mortality was 42.14% among 2462 patients infected with CRKP versus 21.16% in those infected with carbapenem-susceptible K. pneumoniae (CSKP). The mortality of patients with bloodstream infection (BSI) or urinary tract infection was 54.30 and 13.52%, respectively, and 48.9 and 43.13% in patients admitted to the intensive care unit (ICU) or who underwent solid organ transplantation (SOT). Mortality was 47.66% in patients infected with K. pneumoniae carbapenemase-producing K. pneumoniae and 46.71% in those infected with VIM-producing K. pneumoniae. Geographically, mortality reported in studies from North America, South America, Europe, and Asia was 33.24, 46.71, 50.06, and 44.82%, respectively. Our study suggests that patients infected with CRKP have higher mortality than those infected with CSKP, especially in association with BSI, ICU admission, or SOT. We also considered that patients’ survival has a close relationship with their physical condition. Our results imply that attention should be paid to CRKP infection, and that strict infection control measures and new antibiotics are required to protect against CRKP infection. read more read less
View PDF
316 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Annals of Clinical Microbiology and Antimicrobials.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Annals of Clinical Microbiology and Antimicrobials in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Annals of Clinical Microbiology and Antimicrobials guidelines and auto format it.

2. Do you follow the Annals of Clinical Microbiology and Antimicrobials guidelines?

Yes, the template is compliant with the Annals of Clinical Microbiology and Antimicrobials guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Annals of Clinical Microbiology and Antimicrobials?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Annals of Clinical Microbiology and Antimicrobials citation style.

4. Can I use the Annals of Clinical Microbiology and Antimicrobials templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Annals of Clinical Microbiology and Antimicrobials.

5. Can I use a manuscript in Annals of Clinical Microbiology and Antimicrobials that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Annals of Clinical Microbiology and Antimicrobials that you can download at the end.

6. How long does it usually take you to format my papers in Annals of Clinical Microbiology and Antimicrobials?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Annals of Clinical Microbiology and Antimicrobials.

7. Where can I find the template for the Annals of Clinical Microbiology and Antimicrobials?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Annals of Clinical Microbiology and Antimicrobials's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Annals of Clinical Microbiology and Antimicrobials's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Annals of Clinical Microbiology and Antimicrobials an online tool or is there a desktop version?

SciSpace's Annals of Clinical Microbiology and Antimicrobials is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Annals of Clinical Microbiology and Antimicrobials?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Annals of Clinical Microbiology and Antimicrobials?”

11. What is the output that I would get after using Annals of Clinical Microbiology and Antimicrobials?

After writing your paper autoformatting in Annals of Clinical Microbiology and Antimicrobials, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Annals of Clinical Microbiology and Antimicrobials's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Annals of Clinical Microbiology and Antimicrobials?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Annals of Clinical Microbiology and Antimicrobials. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Annals of Clinical Microbiology and Antimicrobials?

The 5 most common citation types in order of usage for Annals of Clinical Microbiology and Antimicrobials are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Annals of Clinical Microbiology and Antimicrobials?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Annals of Clinical Microbiology and Antimicrobials's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Annals of Clinical Microbiology and Antimicrobials in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Annals of Clinical Microbiology and Antimicrobials Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Annals of Clinical Microbiology and Antimicrobials formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template